6.54
price down icon2.24%   -0.15
after-market Dopo l'orario di chiusura: 6.60 0.06 +0.92%
loading
Precedente Chiudi:
$6.69
Aprire:
$6.69
Volume 24 ore:
3.37M
Relative Volume:
1.45
Capitalizzazione di mercato:
$652.19M
Reddito:
$58.36M
Utile/perdita netta:
$-25.72M
Rapporto P/E:
-17.96
EPS:
-0.3641
Flusso di cassa netto:
$-24.91M
1 W Prestazione:
+12.76%
1M Prestazione:
+34.02%
6M Prestazione:
+170.25%
1 anno Prestazione:
+39.15%
Intervallo 1D:
Value
$6.395
$6.73
Intervallo di 1 settimana:
Value
$5.78
$6.865
Portata 52W:
Value
$2.12
$6.865

Aquestive Therapeutics Inc Stock (AQST) Company Profile

Name
Nome
Aquestive Therapeutics Inc
Name
Telefono
908-941-1900
Name
Indirizzo
30 TECHNOLOGY DRIVE, WARREN, NJ
Name
Dipendente
142
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-05
Name
Ultimi documenti SEC
Name
AQST's Discussions on Twitter

Confronta AQST con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
AQST
Aquestive Therapeutics Inc
6.54 809.31M 58.36M -25.72M -24.91M -0.3641
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
141.11 63.55B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.71 44.47B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.00 40.17B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.03 22.99B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
440.00 20.14B 3.08B 1.24B 1.07B 25.61

Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-02 Ripresa Oppenheimer Outperform
2024-12-17 Iniziato Cantor Fitzgerald Overweight
2024-05-10 Iniziato Leerink Partners Outperform
2024-04-11 Iniziato Piper Sandler Overweight
2024-03-28 Iniziato Raymond James Outperform
2021-04-07 Ripresa RBC Capital Mkts Outperform
2019-04-22 Iniziato H.C. Wainwright Buy
2019-01-03 Iniziato Lake Street Buy
2018-08-20 Iniziato JMP Securities Mkt Outperform
2018-08-20 Iniziato RBC Capital Mkts Outperform
Mostra tutto

Aquestive Therapeutics Inc Borsa (AQST) Ultime notizie

pulisher
Oct 10, 2025

Aquestive Therapeutics (AQST) Surges 7.9%: Is This an Indication of Further Gains? - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

Is Aquestive Therapeutics Inc. reversing from oversold territoryJuly 2025 EndofMonth & Reliable Trade Execution Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How to build a dashboard for Aquestive Therapeutics Inc. stockStock Surge & Momentum Based Trading Signals - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Weiss Ratings Reiterates Sell (D-) Rating for Aquestive Therapeutics (NASDAQ:AQST) - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

JMP Securities Maintains Aquestive Therapeutics (AQST) Market Outperform Recommendation - Nasdaq

Oct 09, 2025
pulisher
Oct 09, 2025

What high frequency data says about Aquestive Therapeutics Inc.July 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Aquestive Therapeutics Broadens Patent Estate for Anaphylm™ - GlobeNewswire

Oct 08, 2025
pulisher
Oct 08, 2025

Aquestive Therapeutics Shares Rise After Obtaining 2 New US Patents for Anaphylm Sublingual Film - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Aquestive Therapeutics Obtains 2 New US Patents for Anaphylm Sublingual Film - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Aquestive receives two new patents for oral anaphylaxis treatment By Investing.com - Investing.com Nigeria

Oct 08, 2025
pulisher
Oct 08, 2025

Aquestive receives two new patents for oral anaphylaxis treatment - Investing.com India

Oct 08, 2025
pulisher
Oct 08, 2025

Aquestive Therapeutics Broadens Patent Estate for Anaphylm™ - GlobeNewswire Inc.

Oct 08, 2025
pulisher
Oct 06, 2025

Signal strength of Aquestive Therapeutics Inc. stock in tech scanners2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Aquestive Therapeutics Inc. stock is seen as undervaluedWeekly Profit Summary & Community Verified Watchlist Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Custom watchlist performance reports with Aquestive Therapeutics Inc.2025 Dividend Review & Free Expert Verified Stock Movement Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Statistical indicators supporting Aquestive Therapeutics Inc.’s strengthTrade Analysis Summary & Comprehensive Market Scan Insights - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Advanced analytics toolkit walkthrough for Aquestive Therapeutics Inc.Portfolio Profit Report & AI Forecast for Swing Trade Picks - newser.com

Oct 05, 2025
pulisher
Oct 01, 2025

Aquestive Therapeutics Advances Anaphylm Clinical Development - TipRanks

Oct 01, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics SVP sells $63,000 in shares By Investing.com - Investing.com Nigeria

Sep 29, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics CEO Barber sells $551k in shares By Investing.com - Investing.com Canada

Sep 29, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics (NASDAQ:AQST) CEO Sells $550,798.29 in Stock - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Peter Boyd Sells 10,000 Shares of Aquestive Therapeutics (NASDAQ:AQST) Stock - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics (NASDAQ:AQST) Trading Down 5.3% After Insider Selling - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics SVP sells $63,000 in shares - Investing.com

Sep 29, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics Hits New 52-Week High of $6.00, Up 105.43% - Markets Mojo

Sep 29, 2025
pulisher
Sep 29, 2025

What drives Aquestive Therapeutics Inc stock priceAI-Driven Market Analysis & Master Stock Selection - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

Aquestive Therapeutics Hits New 52-Week High of $6.43 - Markets Mojo

Sep 29, 2025
pulisher
Sep 29, 2025

Is Aquestive Therapeutics Inc a good long term investmentSmall Cap Stock Opportunities & Collaborate and Win Together - earlytimes.in

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about Aquestive Therapeutics Inc stockVolume Weighted Average Price & See Risk Factors Before Making Any Move - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Published on: 2025-09-28 19:22:53 - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Aquestive Therapeutics Sees Stock Surge Following FDA Approval News - timothysykes.com

Sep 28, 2025
pulisher
Sep 27, 2025

AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDA - MSN

Sep 27, 2025

Aquestive Therapeutics Inc Azioni (AQST) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Aquestive Therapeutics Inc Azioni (AQST) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Boyd Peter E.
See Remarks
Sep 26 '25
Sale
6.30
10,000
63,000
278,323
$19.76
price down icon 1.54%
$9.74
price down icon 2.50%
$53.95
price down icon 7.38%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.20%
$136.63
price down icon 1.33%
$440.00
price down icon 1.21%
Capitalizzazione:     |  Volume (24 ore):